Provided by Tiger Fintech (Singapore) Pte. Ltd.

Pacific Biosciences of California

1.17
-0.0300-2.50%
Post-market: 1.180.0050+0.43%19:56 EDT
Volume:4.09M
Turnover:4.87M
Market Cap:348.49M
PE:-1.04
High:1.22
Open:1.20
Low:1.16
Close:1.20
Loading ...

Genetics Tools Face Fund Cuts -- Barron's

Dow Jones
·
15 Feb

SoftBank reports new stakes in PacBio, Recursion Pharmaceuticals

TIPRANKS
·
15 Feb

PACB Stock Down Following In-Line Q4 Earnings, Revio Shipments Fall

Zacks
·
15 Feb

PacBio should return to growth over time, says Canaccord

TIPRANKS
·
15 Feb

Pacific Biosciences of California Shares Reverse Premarket Course, Last up 16% After Q4 Results

THOMSON REUTERS
·
14 Feb

BUZZ-Pacific Biosciences falls on Q4 revenue miss

Reuters
·
14 Feb

UBS Adjusts Price Target on Pacific Biosciences of California to $1.50 From $2, Keeps Neutral Rating

MT Newswires Live
·
14 Feb

Pacific Biosciences of California Shares Down 4.7% Premarket After Q4 Revenue Miss

THOMSON REUTERS
·
14 Feb

Pacific Biosciences of California Inc (PACB) Q4 2024 Earnings Call Highlights: Navigating ...

GuruFocus.com
·
14 Feb

Pacific Biosciences of California (PACB) Reports Q4 Loss, Tops Revenue Estimates

Zacks
·
14 Feb

PacBio (NASDAQ:PACB) Misses Q4 Sales Targets

StockStory
·
14 Feb

Pacific Biosciences of California Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
14 Feb

Pacific Biosciences: Q4 Earnings Snapshot

Associated Press Finance
·
14 Feb

Pacific Biosciences Q4 Adj $(0.20) Beats $(0.21) Estimate, Sales $39.22M Miss $40.16M Estimate

Benzinga
·
14 Feb

BRIEF-Pacific Biosciences of California Q4 Adjusted Net Income USD -55.3 Million Vs. IBES Estimate USD -60.6 Million

Reuters
·
14 Feb

Trump's Cuts to Medical Research Are Hurting These Stocks -- Barrons.com

Dow Jones
·
13 Feb

Largest borrow rate increases among liquid names

TIPRANKS
·
12 Feb

PacBio (PACB) Q4 Earnings Report Preview: What To Look For

StockStory
·
12 Feb

Pacific Biosciences of California Inc expected to post a loss of 21 cents a share - Earnings Preview

Reuters
·
12 Feb

Analysts Offer Insights on Healthcare Companies: Pacific Biosciences (PACB), Immunovant (IMVT) and 4D Molecular Therapeutics (FDMT)

TIPRANKS
·
11 Feb